| 中文名称 | 英文名称 | CAS号 | 化学式 |
|---|---|---|---|
| L-(+)-N-boc-2-苯基甘氨酸酰肼 | L-(+)-N-BOC-phenylglycine hydrazide | 1043912-48-6 | C13H19N3O3 |
| L-(+)-2-氰基-3-苯基丙基甲酸酯 | L-(+)-2-cyano-3-phenylpropyl formate | 104876-36-0 | C11H11NO2 |
| L(-)-甘露糖 | L-mannose | 10030-80-5 | C6H12O6 |
| L(+)-2-氨基-6-(O,O'-二乙基磷酸)己酸 | 2-Azaniumyl-6-(diethoxyphosphoryl)hexanoate | 184095-99-6 | C10H22NO5P |
| L(+)-2-氨基-4-溴丁酸氢溴酸盐 | (2S)-2-amino-4-bromobutanoic acid hydrobromide | 15159-65-6 | BrH*C4H8BrNO2 |
| Kv3调节剂1 | 5,5-dimethyl-3-[2-(7-methylspiro[2H-benzofuran-3,1'-cyclopropane]-4-yl)oxypyrimidin-5-yl]imidazolidine-2,4-dione | 1380696-64-9 | C20H20N4O4 |
| Kryptofix222[18F]钾盐 | K[<sup>18</sup>F]F-K<sub>222</sub> complex | 107371-67-5 | C18H36N2O6*F*K |
| KY02111抑制剂 | N-(6-chlorobenzo[d]thiazol-2-yl)-3-(3,4-dimethoxyphenyl)propanamide | 1118807-13-8 | C18H17ClN2O3S |
| KW-3902; HMR-4902; 1,3-二丙基-8-(3-正金刚烷基)黄嘌呤 | rolofylline | 136199-02-5 | C20H28N4O2 |
| KPT185抑制剂 | KPT-185 | 1333151-73-7 | C16H16F3N3O3 |
| KO-对甲苯基 | potassium p-cresolate | 1192-96-7 | C7H7KO |
| KN-93(水溶性) | N-[2-[N-(4-Chlorocinnamyl)-N-methylaminomethyl]phenyl]-N-(2-hydroxyethyl)-4-methoxybenzenesulfonamide phosphate salt | 1188890-41-6 | C26H29ClN2O4S*H3O4P |
| KN-92磷酸盐 | KN-92 phosphate | 1135280-28-2 | C24H28ClN2O7PS |
| KGA和GAC抑制剂(CB-839) | CB-839 | 1439399-58-2 | C26H24F3N7O3S |
| KB-R7943甲磺酰酸盐 | 2-[2-[4-(4-Nitrobenzyloxy)phenyl]ethyl]isothiourea mesylate | 182004-65-5 | C17H21N3O6S2 |
| K-二氟硫代磷酸酯 | K-difluoro thiophosphate | 17023-36-8 | F2PS2*K |
| JZL184抑制剂 | 4-nitrophenyl 4-[bis(2H-1,3-benzodioxol-5-yl)(hydroxy)methyl]piperidine-1-carboxylate | 1101854-58-3 | C27H24N2O9 |
| JZL-195抑制剂 | (4-Nitrophenyl) 4-[(3-phenoxyphenyl)methyl]piperazine-1-carboxylate | 1210004-12-8 | C24H23N3O5 |
| JWH073丁酸代谢物 | 4-[3-(naphthalene-1-carbonyl)-1H-indol-1-yl]butanoic acid | 1307803-52-6 | C23H19NO3 |
| JWH0187-羟基吲哚代谢物 | (7-hydroxy-1-pentyl-1H-indol-3-yl)(naphthalen-1-yl)methanone | 1307803-45-7 | C24H23NO2 |
| JWH-398((4-氯萘-1-基)(1-pentylindol-3-基)甲酮)标准品 | JWH-398 | 1292765-18-4 | C24H22ClNO |
| JWH-1225-羟基戊基 | JWH-122 N-(5-hydroxypentyl)metabolite | 1379604-68-8 | C25H25NO2 |
| JWH-0732-羟基吲代谢物 | JWH 073 2-hydroxyindole metabolite | 1427325-54-9 | C23H21NO2 |
| JWH-072-N-羧酸 | JWH 018 N-propanoic acid metabolite | 1451369-32-6 | C22H17NO3 |
| JWH-018N-戊基-5-羧酸 | 5-[3-(naphthalene-1-carbonyl)-1H-indol-1-yl]pentanoic acid | 1254475-87-0 | C24H21NO3 |
| JWH-0184-羟基戊基代谢物标准品 | (1-(4-hydroxypentyl)-1H-indol-3-yl)(naphthalen-1-yl)methanone | 1320363-47-0 | C24H23NO2 |
| JNJ-40346527游离态 | 4-cyano-N-(2-(4,4-dimethylcyclohex-1-en-1-yl)-6-(2,2,6,6-tetramethyltetrahydro-2H-pyran-4-yl)pyridin-3-yl)-1H-imidazole-2-carboxamide | 1142363-52-7 | C27H35N5O2 |
| JAK激酶抑制剂 | Peficitinib hydrobromide | 1353219-05-2 | C18H23BrN4O2 |
| JAK2抑制剂V,Z3 | NSC 42834 | 195371-52-9 | C23H24N2O |
| I型P21激活激酶(PAK)抑制剂(FRAX597) | FRAX597 | 1286739-19-2 | C29H28ClN7OS |
| Ivacaftor苯磺酸盐 | N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide.besylate | 1134822-09-5 | C6H6O3S*C24H28N2O3 |
| Im-bzl-L-组氨酸甲酯 | N'-benzyl-L-histidine methyl ester | 19817-75-5 | C14H17N3O2 |
| Idasanutlin(4-((2R,3S,4R,5S)-3-(3-氯-2-氟苯基)-4-(4-氯-2-氟苯基)-4-氰基-5-新戊基吡咯烷-2-甲酰胺)-3-甲氧基苯甲酸;) | idasanutlin | 1229705-06-9 | C31H29Cl2F2N3O4 |
| ITI214自由基 | (6aR,9aS)-5,6a,7,8,9,9a-hexahydro-5-methyl-3-(phenylamino)-2-((4-(6-fluoropyridin-2-yl)phenyl)methyl)cyclopent[4,5]imidazo[1,2-a]pyrazolo[4,3-e]pyrimidin-4(2H)-one | 1160521-50-5 | C29H26FN7O |
| IRAK 抑制剂 6; N-[2-甲氧基-4-(4-吗啉基)苯基]-2-(3-吡啶基)-4-噻唑甲酰 | IRAK inhibitor 6 | 1042672-97-8 | C20H20N4O3S |
| IR-775 氯化物 | IR-775 chloride | 199444-11-6 | C32H36ClN2*Cl |
| IR-1048四氟硼酸盐 | 1-(2,6-dimethylphenyl)-3-(3-propanol)thiourea | 120077-91-0 | C12H18N2OS |
| IPI145中间体-5 | 8-chloro-2-phenyl-3-((1S)-1-(9-(tetrahydro-2H-pyran-2-yl)-9H-purin-6-ylamino)ethyl)isoquinolin-1(2H)-one | 1350643-73-0 | C27H25ClN6O2 |
| IPI-926盐酸盐 | N-[(3R,3'R,3'aS,4aR,6'S,6aR,6bS,7'aR,9S,12aS,12bS)-3',6',11,12b-tetramethylspiro[1,2,3,4,4a,5,6,6a,6b,7,8,10,12,12a-tetradecahydronaphtho[2,1-a]azulene-9,2'-3a,4,5,6,7,7a-hexahydro-3H-furo[3,2-b]pyridin-4-ium]-3-yl]methanesulfonamide;chloride | 1169829-40-6 | C29H48N2O3S*ClH |
| IPI-549,一种有效的选择性PI3KΓ抑制剂 | IPI-549 | 1693758-51-8 | C30H24N8O2 |
| IPDI二乙基己酯 | monoderm I-8 | 185568-15-4 | C28H54N2O4 |
| IPDI二丁基己酯 | Carbamic acid, (3-((((isodecyloxy)carbonyl)amino)methyl)-3,5,5-trimethylcyclohexyl)-, isodecyl ester | 185568-16-5 | C32H62N2O4 |
| IPAG(1-(4-碘苯基)-3-(2-金刚烷基)胍) | 1-(4-Iodophenyl)-3-(2-adamantyl)guanidine | 193527-91-2 | C17H22IN3 |
| IOTA-角叉菜 | [(2R,3S,4R,5R,6S)-6-[[(1R,3S,4R,5R,8S)-3,4-dihydroxy-2,6-dioxabicyclo[3.2.1]octan-8-yl]oxy]-4-[[(1R,3R,4R,5R,8S)-8-[(2S,3R,4R,5R,6R)-3,4-dihydroxy-6-(hydroxymethyl)-5-sulfonatooxyoxan-2-yl]oxy-4-hydroxy-2,6-dioxabicyclo[3.2.1]octan-3-yl]oxy]-5-hydroxy-2-(hydroxymethyl)oxan-3-yl] sulfate | 11114-20-8 | C24H36O25S2-2 |
| IN1861,1,2-双(5-(三甲基锡基)噻吩-2-基)乙炔 | 1,2-bis(5-(trimethylstannyl)thiophen-2-yl)ethyne | 1610057-24-3 | C16H22S2Sn2 |
| IN1771,(4,8-双(5-(2-乙基己基)-4-氟噻吩基)苯并[1,2-B:4,5-B']二噻吩基)双(三甲基锡基) | (4,8-bis(5-(2-ethylhexyl)-4-fluorothiophene-2-yl)benzo[1,2-b:4,5-b’]dithiophene-2,6-diyl)bis(trimethylstanne) | 1514905-25-9 | C40H56F2S4Sn2 |
| IN1537,7-溴-4,4,9,9-四己基-4,9-二氢-S-茚并[1,2-B:5,6-B']二噻吩-2-甲醛 | 7-bromo-4,9-dihydro-4,4,9,9-tetrahexyl-s-indaceno[1,2-b:5,6-b']dithiophene-2-carbaldehyde | 1509939-05-2 | C41H57BrOS2 |
| IN1273,5,5'-二溴-3,3'-双(2-(2-(2-甲氧基乙氧基)乙氧基)乙氧基)-2,2'-联噻吩 | 5,5'-dibromo-3,3'-bis(2-(2-(2-methoxyethoxy)ethoxy)ethoxy)-2,2'-bithiophene | 1974310-58-1 | C22H32Br2O8S2 |
| IM-017(9-[(R)-2-{9'-腺嘌呤基[R)-2-丙基)]}-磷酰甲氧基丙基]-腺嘌呤) | [[(2R)-1-(6-Amino-9H-purin-9-yl)propan-2-yloxy]methyl]phosphonic Acid Mono[(2R)-1-(6-amino-9H-purin-9-yl)propan-2-yl] Ester | 1878175-77-9 | C17H23N10O4P |
| IKKε-IN-1抑制剂 | 5-[2-[(4-morpholinophenyl)amino]pyrimidin-4-yl]-2-tetrahydropyran-4-yloxy-benzonitrile | 1292310-49-6 | C26H27N5O3 |